Optimizing osteoporosis management in CKD patients

Optimizing osteoporosis management in CKD patients

Saved in:

Bibliographic Details
Main Authors:	Yong Wang, Wei Zhou
Format:	Article
Language:	Spanish
Published:	Elsevier 2025-04-01
Series:	Nefrología
Online Access:	http://www.sciencedirect.com/science/article/pii/S0211699524001218
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

In response to optimizing osteoporosis management in CKD patients
by: Jordi Bover, et al.
Published: (2025-04-01)

WCN24-1258 HIGH PREVALENCE OF OSTEOPOROSIS IN ELDERLY PATIENTS WITH ADVANCED CKD: CALL FOR ACTION!
by: Sayuri Kuhnen Hayashi, et al.
Published: (2024-04-01)

Framework of Guidelines for Management of CKD in Asia
by: Carol Pollock, et al.
Published: (2024-04-01)

Patient Perceptions of a Population Health Management Program to Improve Kidney Care: Optimizing care in CKD
by: Linda-Marie U. Lavenburg, et al.
Published: (2025-07-01)

Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study
by: Michael B. Sohn, et al.
Published: (2024-03-01)

Effect of transcolonic therapy on gastrointestinal motility in patients with CKD
by: SU Hai-hua, et al.
Published: (2017-01-01)

Roxadustat in CKD and transplant patients: A new era in anemia management
by: Muhammad Tassaduq Khan, et al.
Published: (2025-03-01)

Inside CKD: Cost-Effectiveness of Multinational Screening for CKD
by: Navdeep Tangri, et al.
Published: (2025-04-01)

Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
by: Soon Kyu Lee, et al.
Published: (2025-01-01)

Updates on New Therapies for Patients with CKD
by: Tushar Tarun, et al.
Published: (2024-01-01)

Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
by: Rui Shi, et al.
Published: (2025-04-01)

Results from a cross-specialty consensus on optimal management of patients with chronic kidney disease (CKD): from screening to complications
by: Carol Pollock, et al.
Published: (2024-03-01)

Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits
by: Thierry Hannedouche, et al.
Published: (2025-08-01)

Statin Use and the Progression of Coronary Artery Calcification in CKD: Findings From the KNOW-CKD Study
by: Jihyun Yang, et al.
Published: (2024-10-01)

Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
by: Soon Kyu Lee, et al.
Published: (2025-04-01)

Clinical Significance of FGF-23 in Patients with CKD
by: Domenico Russo, et al.
Published: (2011-01-01)

Dotinurad Treatment for Patients With Hyperuricemia Complicating CKD
by: Katsuyuki Tanabe, et al.
Published: (2025-06-01)

Bisphosphonates in the Management of Patients with Postmenopausal Osteoporosis; Back to the Future
by: Socrates E. Papapoulos, et al.
Published: (2025-07-01)

CKD Knowledge and CKD Report Card Use During a Nephrology Encounter: A Randomized Trial
by: Jillian Bowman, et al.
Published: (2025-05-01)

Early Intervention, Big Savings: The Future of CKD Management in Thailand
by: Blake Angell, et al.
Published: (2024-08-01)

Anemia in Pregnancy With CKD
by: Margriet F.C. de Jong, et al.
Published: (2024-05-01)

New Issues in the Management of Osteoporosis
by: Joonas Sirola, et al.
Published: (2011-01-01)

Applicability evaluation of the GFR equations in Chinese patients with diabetes mellitus complicated with CKD
by: LV Xiao-yang, et al.
Published: (2019-01-01)

Holistic Impact of CKD: A Clinical, Economic, and Environmental Analysis by IMPACT CKD
by: Naveen Rao, et al.
Published: (2025-07-01)

Low Energy Diets for Obesity and CKD (SLOW-CKD Randomized Feasibility Study)
by: Marguerite M. Conley, et al.
Published: (2025-07-01)

Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
by: Soon Kyu Lee, et al.
Published: (2025-04-01)

CKD patients comorbid with hypertension are associated with imbalanced gut microbiome
by: Pan Wang, et al.
Published: (2025-02-01)

Characterization of Monogenic Kidney Disease in Older Patients With CKD
by: Elhussein A.E. Elhassan, et al.
Published: (2025-07-01)

Prevalence of dysmagnesemia among CKD patients in North India
by: Shailata Prisi, et al.
Published: (2025-03-01)

Effects of Semaglutide on CKD in Patients With Type 2 Diabetes
by: Sradha S. Kotwal, et al.
Published: (2025-02-01)

Systematic Review of Patient and Caregiver Involvement in CKD Research
by: Talia Gutman, et al.
Published: (2025-06-01)

Evaluation of CRP SNV rs2808630 and acute proinflammatory biomarkers in patients with CKD and PLHIV with CKD: a case-control study
by: Andrea Torres-Rojas, et al.
Published: (2025-05-01)

Randomized Trial of Pegmolesatide for the Treatment of Anemia in Patients With Nondialysis CKD
by: Jianteng Xie, et al.
Published: (2025-03-01)

Management of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
by: Pringgodigdo Nugroho
Published: (2021-12-01)

Diagnosis and Management of Osteoporosis in Children and Adolescents
by: Hye Young Jin, et al.
Published: (2023-10-01)

The Promise of Dotinurad for Hyperuricemia in CKD
by: Amy S. Li, et al.
Published: (2025-06-01)

The relationship between blood pressure variability and kidney injury among CKD patients
by: LI Ya, et al.
Published: (2016-01-01)

Nonpharmacologic and Nonsurgical Weight Management Interventions for Patients With Advanced CKD: A Scoping Review of the Medical Literature
by: Kamel Omer, et al.
Published: (2025-06-01)

Impact of hospital-based early detection on management in chronic kidney disease: the CKD Stewardship study (CKD-S) – protocol for a prospective, multicentre, observational cohort study
by: John Saunders, et al.
Published: (2025-03-01)

Problems in patient management and the impact of osteoporosis therapy on the incidence of clinical infection
by: O. M. Lesnyak, et al.
Published: (2021-07-01)